Report Feature
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genomic and proteomic tool market report, please download the report brochure.
In this market, next-generation sequencing is the largest type of genomic and proteomic, whereas proteogenomic research is the largest application. Growth in various segments of the genomic and proteomic market are given below:
- Sequencing Technologies
- Sangers Sequencing & Next Generation Sequencing
- PCR (Polymerase Chain Reaction) Technologies
- Flow Cytometry
- Mass Spectrometry
- Nucleic Acid Sample Preparation Technologies
- Separation Technologies
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Sample Preparation
- Electrophoresis
- Biochips and Microarrays
- Chromatography
- Mass Spectrometry
- Thermal Cyclers
- Next-Generation Sequencing
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Agriculture and Animal Husbandry
- Drug Discovery
- Forensics
- Proteogenomic Research
- Disease Identification
- Diagnostics and Control
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the genomic and proteomic tool companies profiled in this report include 3Billion, Bio-Rad Laboratories, GE Healthcare, Novogene, Qiagen, Thermo Fisher Scientific, and Waters.
Lucintel forecasts that next-generation sequencing will remain the fastest growing type segment over the forecast period due to its declining cost and increasing clinical opportunities.
Within this market, proteogenomic research will remain the largest application segment over the forecast period due to increasing research and development expenditure related to proteomics and rising number of genomic research projects.
North America will remain the largest region over the forecast period due to increasing prevalance of cancer, increasing research activities related to genomics and proteomics, and presence of advanced healthcare infrastructure & research facilities in the region.
|
Features of the Global Genomic and Proteomic Tool Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global genomic and proteomic tool market by technology and product (sequencing technologies (sangers sequencing & next generation sequencing, PCR technologies, flow cytometry, mass spectrometry, and nucleic acid sample preparation technologies) and separation technologies), type (sample preparation, electrophoresis, biochips and microarrays, chromatography, mass spectrometry, thermal cyclers, and next-generation sequencing), application (agriculture and animal husbandry, drug discovery, forensics, proteogenomics research, disease identification, diagnostics and control, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genomic and proteomic tool market? Q.5 What are the business risks and threats to the global genomic and proteomic tool market? Q.6 What are the emerging trends in this genomic and proteomic tool market and the reasons behind them? Q.7 What are some changing demands of customers in this genomic and proteomic tool market? Q.8 What are the new developments in this genomic and proteomic tool market? Which companies are leading these developments? Q.9 Who are the major players in this genomic and proteomic tool market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this genomic and proteomic tool market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global genomic and proteomic tool market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Technology and Product (Sequencing Technologies (Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, and Nucleic Acid Sample Preparation Technologies) and Separation Technologies), Type (Sample Preparation, Electrophoresis, Biochips & Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, and Next-Generation Sequencing), and Application (Agriculture & Animal Husbandry, Drug Discovery, Forensics, Proteogenomics Research, Disease Identification, Diagnostics & Control, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.